Gerresheimer AG (ETR:GXI)
27.06
-1.06 (-3.77%)
At close: Dec 16, 2025
Gerresheimer AG Revenue
Gerresheimer AG had revenue of 560.68M EUR in the quarter ending August 31, 2025, with 12.47% growth. This brings the company's revenue in the last twelve months to 2.25B, up 11.83% year-over-year. In the fiscal year ending November 30, 2024, Gerresheimer AG had annual revenue of 2.04B with 2.28% growth.
Revenue (ttm)
2.25B
Revenue Growth
+11.83%
P/S Ratio
0.41
Revenue / Employee
166.26K
Employees
12,142
Market Cap
927.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | 2.04B | 45.42M | 2.28% |
| Nov 30, 2023 | 1.99B | 173.39M | 9.54% |
| Nov 30, 2022 | 1.82B | 319.09M | 21.30% |
| Nov 30, 2021 | 1.50B | 79.22M | 5.58% |
| Nov 30, 2020 | 1.42B | 26.53M | 1.91% |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Gerresheimer AG News
- 22 days ago - Pharmaceutical Packaging Market worth $364.11 billion by 2030 at 15.8%, says MarketsandMarkets™ - Benzinga
- 26 days ago - EQS-News: Gerresheimer AG: Change in the Supervisory Board - Wallstreet:Online
- 4 weeks ago - EQS-News: Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets - Wallstreet:Online
- 4 weeks ago - EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 6 weeks ago - Q2 2025 Gerresheimer AG Earnings Call Transcript - GuruFocus
- 7 weeks ago - Gerresheimer Appoints Uwe Röhrhoff As Interim CEO, Succeeding Dietmar Siemssen - Nasdaq
- 7 weeks ago - Gerresheimer appoints Uwe Röhrhoff as new interim CEO - Reuters
- 7 weeks ago - EQS-News: Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen - Wallstreet:Online